绥美凯的适应症

Indications of India's Emcure Pharmaceuticals: Suitable for the treatment of adults and adolescents over 12 years old (with a weight of at least 40 kg) infected with human immunodeficiency virus (HIV).

Dolutegravir tablets (Simeike) are an antiviral drug. The main function of Simeike Inbec is to treat AIDS. Dolutegravir can inhibit HIV integrase by binding to the active site of integrase and blocking the strand transfer step of reverse transcription deoxyribonucleic acid (DNA) integration (a key step in the HIV replication cycle).

Trimax Inbec was initially approved for marketing in the United States in 2014 and is currently the only three-in-one compound drug containing dolutegravir (DTG). Suimeikai Inbec has been approved for marketing in 50 countries and regions, and has been recommended by many authoritative academic institutions and authoritative guidelines in Europe and the United States as the first-line first-line treatment for patients with HIV infection.

The original drug of Suimeike Inbec is more expensive, so many patients choose the Indian version of Suimeike. Due to patent protection restrictions, many drugs are prohibited from being copied in most countries around the world. However, due to the protection of India's special patent laws, Indian Emcure Pharmaceuticals can produce drugs that are almost as effective as the original drugs and have high cost performance.

Suimeikan Inbec, like most drugs, may have some side effects after long-term use, which may affect the patient's body. However, Suimeikan Inbec is relatively safe. Common side effects are nausea/insomnia/dizziness/headache, etc.

Abacavir, one of the ingredients in Dolutegra, may cause hypersensitivity reactions. The most common symptoms of hypersensitivity reactions are: fever (high fever) and rash. Other common reactions include: nausea/vomiting/diarrhea/abdominal pain/tiredness, etc. Hypersensitivity reactions can occur at any time during treatment with Trimax Inbec, but are more common during the first 6 weeks of treatment. During the treatment of Suimeikan Inbec, the correct usage and dosage should be followed. It is a fixed-dose tablet and cannot be used for patients who need dose adjustment. If the patient has special circumstances, he or she needs to change the use of other drugs according to the actual situation by an experienced doctor.